Skip to main content

Actors and Networks database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Additional complementary work by other organisations on GCT stakeholders mapping can be found here.

A scientific paper on actors has also been published in Humanities and Social Sciences Communications. You can find its lay summary here.

Showing 10 of 372

The Institute of Health Carlos III – Health technology assessment Agency (Instituto de Salud Carlos III – Agencia de Evaluación de Tecnologías Sanitarias) (ISSIII AETS)

Region/Country:  
  • Countries in the EU/EEA
  • Spain

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

The Netherlands Patents Office (Octrooicentrum Nederland)

Region/Country:  
  • Countries in the EU/EEA
  • Netherlands

Type of Actor:

  • Regulators
  • Patent Offices
  • National Patent Offices

Development Stage:

  • Fundamental Research

The Roslin Institute, The University of Edinburgh (The Roslin Institute)

Region/Country:  
  • UK

Type of Actor:

  • Non-profit Research Organisations
  • Academic Bodies

Development Stage:

  • Fundamental Research

Additional information

The Roslin Institute offers unique expertise and infrastructure to conduct pioneering animal biosciences, aiming to achieve sustainable agriculture, control diseases and enhance health.

Transparency Commission – French HAS (Commission de la Transparence – HAS) (CT)

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Regulators
  • Payers

Development Stage:

  • Commercialisation

Additional information

The Transparency Commission is a scientific body of the HAS made up of doctors, pharmacists, methodologists, experts in medical evaluation and public health, and members chosen from among the members of an association of patients and users of the healthcare system. The HAS is independent of manufacturers and payers, and is responsible for advising the public authorities on the reimbursement and pricing of medicinal products.

TÜV NORD CERT GmbH

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

TUV NORD Polska Sp. z o.o

Region/Country:  
  • Countries in the EU/EEA
  • Poland

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

TUV Rheinland Italia SRL

Region/Country:  
  • Countries in the EU/EEA
  • Italy

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

TÜV Rheinland LGA Products GmbH

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

TÜV SÜD Danmark

Region/Country:  
  • Countries in the EU/EEA
  • Denmark

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

TÜV SÜD Product Service GmbH

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts